“You suppose ANYONE @ CYDY would think might be smart to listen" to Dr Patterson presentation--see what markers he is measuring--make sure LL is going to meet each and every endpoint they submit for trial??”

There was some research posted on hear a month or two ago on the lab(s) that CYDY is currently using vs Incelldx. If I remember correctly, CYDY’s current labs don’t have the same capabilities as Incelldx. Additionally, I think cost may be a big factor as to why CYDY didn’t include diagnostics in the M2M or S/C trial and May influence its use in this trial as well.